Lupus Insight Prize Grant

Lupus Insight Prize Grant

Status: ACTIVE
Funder: Lupus Research Alliance Inc
Amount: US $100,000
Last Updated: December 10, 2025

Summary

The Lupus Insight Prize, awarded by the Lupus Research Alliance, recognizes groundbreaking scientific insights into lupus, an autoimmune disease with limited treatment options. This prize aims to honor recent discoveries that advance understanding and treatment of lupus, while fostering further impactful research. The recipient's institution will receive $100,000 to support this vital work. Nominations are open to researchers worldwide, with specific eligibility criteria to ensure deserving candidates are recognized for their innovative contributions in this field.

Overview

Lupus Research Alliance Lupus is a complex autoimmune disease that is difficult to diagnose, treat, and defeat, with only one treatment approved in nearly 60 years. The Lupus Research Alliance is committed to funding promising investigations that help advance the understanding of lupus, develop an array of more effective treatments with fewer and less severe side effects, and ultimately find a cure. Lupus Insight Prize The Lupus Research Alliance (LRA) requests nominations for the Lupus Insight Prize recognizing and honoring significant scientific insights relevant to understanding the causes, pathogenesis, or treatment of lupus. The Prize also aims to stimulate further advances leading to improved outcomes for lupus patients and ultimately to a cure. Prize Objectives The primary objective of the Lupus Insight Prize is to identify and recognize an outstanding investigator with a documented record of creativity and innovation who has made a novel research discovery in scientific domains relevant to lupus. The Prize is not a lifetime achievement award. Rather, the Lupus Insight Prize is given for a specific, significant, and recent (within the past five years) discovery relevant to lupus. In addition to recognizing a specific insight or discovery, the Prize also aims to direct the talents of the Prize recipient toward further high impact research achievement and testing of the insight in lupus. This should shift the current paradigms and significantly advance the understanding or treatment of lupus. Secondary objectives of the Prize are to: raise the visibility of lupus as a significant medical condition among the general public and demonstrate the determination of the LRA to surmount the challenges of this complex and debilitating disease through the support of research. Prize Funds The institution of the Prize recipient, unless the recipient is working for a biotechnology or a pharmaceutical company, will receive $100,000 to be used at the discretion of the recipient with the expectation that the funds will be used to apply the discovery/insight for which the Prize was awarded toward advancing understanding of the genetic, environmental, molecular, immunologic, or cellular aspects of lupus or its treatment. No monetary award can be given to investigators currently working in industry. The Prize can be transferred to another institution if the recipient changes their affiliation but cannot be renewed. The funds are to be spent within one year of the start date of the award. The award will be made in US dollars and no adjustments will be made to offset any currency fluctuations. A maximum of 20% of the total dollar amount can be utilized towards the recipient’s salary and fringe benefits. In addition, a maximum of 20% of the total dollar amount can be utilized towards the purchase of laboratory equipment. Under no circumstances can any of the funds be used to pay institutional overhead or indirect costs. The total amount of the Prize must be utilized for the described research within one year of the start date of the award.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Nominations of basic, clinical, and translational scientists will be considered. Nominations will be accepted for investigators of any age or rank affiliated with an academic, biomedical, research, government, or biotechnology/pharmaceutical institution worldwide.Should an investigator currently working in the biotechnology/pharmaceutical industry be awarded the Lupus Insight Prize, recognition will be limited to the presentation of the Award plaque and the celebrations associated with this event at the FOCIS meeting.Only one nomination will be accepted per investigator. Each nominator can nominate only one candidate per year. Once a nomination has been submitted, it will remain active for up to four years (the original submission plus three additional years), unless withdrawn by the nominator.Nominations carried from prior years can be updated, if necessary, by the nomination deadline. There are no geographic restrictions on the nominee or the nominator.

Ineligibility

No monetary grant award can be given to investigators currently working in industry. Co-Investigators or teams of investigators are not eligible for this Prize. Self-nominations are not allowed.Nominators are discouraged from simultaneously serving as supporters for other Lupus Insight Prize nominees.